|
|
Volumn 11, Issue 8, 2012, Pages 590-591
|
|
Deal watch: Roche deal targets glutamate in neurodevelopmental disorders
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID B RECEPTOR;
4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT;
ARBACLOFEN;
FRAGILE X MENTAL RETARDATION PROTEIN;
GLUTAMATE RECEPTOR ANTAGONIST;
GLUTAMIC ACID;
MEMANTINE;
METABOTROPIC RECEPTOR 5;
METABOTROPIC RECEPTOR ANTAGONIST;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
OCTAHYDRO 4 HYDROXY 4 [(3 METHYLPHENYL)ETHYNYL] 1H INDOLE 1 CARBOXYLIC ACID METHYL ESTER;
RG 7090;
SEROTONIN 3 RECEPTOR;
UNCLASSIFIED DRUG;
ADVERSE OUTCOME;
AMINO ACID TRANSPORT;
AUTISM;
CLINICAL EFFECTIVENESS;
CLINICAL FEATURE;
COGNITIVE DEFECT;
DEVELOPMENTAL DISORDER;
DISSOCIATIVE DISORDER;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TARGETING;
FRAGILE X SYNDROME;
GENE MUTATION;
GENETIC ASSOCIATION;
HUMAN;
NEUROLOGIC DISEASE;
NONHUMAN;
PHENOTYPIC VARIATION;
PRESYNAPTIC POTENTIAL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
SYNAPTIC TRANSMISSION;
CHILD;
CHILD DEVELOPMENT DISORDERS, PERVASIVE;
COOPERATIVE BEHAVIOR;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUG INDUSTRY;
EXCITATORY AMINO ACID ANTAGONISTS;
FRAGILE X SYNDROME;
GABA-B RECEPTOR AGONISTS;
GLUTAMIC ACID;
HUMANS;
RECEPTORS, METABOTROPIC GLUTAMATE;
|
|
EID: 84864548379
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3808 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|
